EP4285902
Auðgaður sýru alfa-glúkósíðasi til meðhöndlunar á Pompe-sjúkdómi
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
29.12.2016EP published:
19.11.2025EP application number:
23188938.7
EP translation filed:
18.2.2026Grant published:
11.3.2026EPO information:
European Patent Register
Max expiry date:
28.12.2036Expiry date:
28.12.2026Next due date:
31.12.2026
Title in English:
AUGMENTED ACID ALPHA-GLUCOSIDASE FOR THE TREATMENT OF POMPE DISEASELanguage of the patent:
English
Timeline
Today
29.12.2016EP application
19.11.2025EP Publication
18.2.2026Translation submitted
11.3.2026Registration published
28.12.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
Do, Hung V.Address:
Philadelphia, 19104, US
Name:
Khanna, RichieAddress:
Philadelphia, 19104, US
Name:
Gotschall, RussellAddress:
Philadelphia, 19104, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562272890 PDate:
30.12.2015Country:
US
Number:
201662300479 PDate:
26.2.2016Country:
US
Number:
201662315412 PDate:
30.3.2016Country:
US
Number:
201662402454 PDate:
30.9.2016Country:
US
Number:
201662428867 PDate:
1.12.2016Country:
US
Number:
201662431791 PDate:
8.12.2016Country:
US
Classification
Categories:
A61K 38/47, A61K 31/445, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 29.12.2025
Expires: 28.12.2026
Payer: Árnason Faktor ehf.